We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2013 by Cong-xin Huang, Wuhan University.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01612260
First Posted: June 5, 2012
Last Update Posted: January 8, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Chinese Academy of Medical Sciences, Fuwai Hospital
Fudan University
Shanghai Changzheng Hospital
Nanjing Medical University
Third Military Medical University
Information provided by (Responsible Party):
Cong-xin Huang, Wuhan University
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)